Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1 37Phase 1/2 19Phase 3 16Phase NA 5Phase 4 2Phase 2/3 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 2Myelodysplastic Syndromes 2Leukemia, Lymphocytic, Chronic, B-Cell 2Neoplasms, Plasma Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphoid 1Leukemia 1Hematologic Neoplasms 1

Interventions

Rituximab 4Cyclophosphamide 4pirtobrutinib 3fludarabine 2Chlorambucil 2venetoclax 1ofatumumab 1idelalisib 1ibrutinib 1fludarabine phosphate 1acalabrutinib 1Valganciclovir 1Thiotepa 1Sirolimus 1Radiotherapy 1Prednisone 1Pneumococcal Vaccines 1Pentostatin 1Filgrastim 1Everolimus 1Biopsy, Needle 1Bendamustine Hydrochloride 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Lymphocytic, Chronic, B-Cell × fludarabine × Clear all
NCT01283386 2019-03-14

A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status

Hoffmann-La Roche

Phase 4 Terminated
26 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01271010 2018-03-20

A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status

Hoffmann-La Roche

Phase 4 Terminated
89 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡